These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35541591)

  • 1. Retracted Article: LncRNA OIP5-AS1 contributes to ox-LDL-induced inflammation and oxidative stress through regulating the miR-128-3p/CDKN2A axis in macrophages.
    Li X; Cao Q; Wang Y; Wang Y
    RSC Adv; 2019 Dec; 9(71):41709-41719. PubMed ID: 35541591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.
    Zheng Z; Zhang G; Liang X; Li T
    Mol Cell Biochem; 2021 Jan; 476(1):443-455. PubMed ID: 32990894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.
    Zhang C; Yang H; Li Y; Huo P; Ma P
    Mol Cell Biochem; 2020 Apr; 467(1-2):15-25. PubMed ID: 32072428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of OIP5-AS1 Protects Endothelial Cells From ox-LDL-Triggered Injury by Regulating KLF5 Expression via Sponging miR-135a-5p.
    Zhao M; Yang Y; Li J; Lu M; Wu Y
    Front Cardiovasc Med; 2021; 8():596506. PubMed ID: 33778018
    [No Abstract]   [Full Text] [Related]  

  • 5. Long Noncoding RNA OIP5-AS1 Contributes to the Progression of Atherosclerosis by Targeting miR-26a-5p Through the AKT/NF-κB Pathway.
    Ren M; Wang T; Han Z; Fu P; Liu Z; Ouyang C
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):635-644. PubMed ID: 32833899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA OIP5-AS1 accelerates ox-LDL-treated HUVECs injury by NF-κB pathway via miR-30c-5p.
    Zhang L; Li Q; Chen Y; Zhu Q
    Clin Hemorheol Microcirc; 2021; 78(4):449-460. PubMed ID: 33867356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA OIP5-AS1 promotes the proliferation and migration of vascular smooth muscle cells via regulating miR-141-3p/HMGB1 pathway.
    Dong H; Jiang G; Zhang J; Kang Y
    Am J Med Sci; 2022 Jun; 363(6):538-547. PubMed ID: 35278365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted Article: Knockdown of long non-coding RNA OIP5-AS1 suppresses cell proliferation and migration in ox-LDL-induced human vascular smooth muscle cells (hVMSCs) through targeting miR-152-3p/PAPPA axis.
    Yang X; Li Z; Zhang L; Wu X; Kang Q; Li L
    RSC Adv; 2019 Oct; 9(56):32499-32509. PubMed ID: 35702340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression.
    Wang Y; Wang H; Ruan J; Zheng W; Yang Z; Pan W
    Cancer Cell Int; 2020; 20():155. PubMed ID: 32410883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of LncRNA OIP5-AS1 Induced by IL-1β Aggravates Osteoarthritis via Regulating miR-29b-3p/PGRN.
    Zhi L; Zhao J; Zhao H; Qing Z; Liu H; Ma J
    Cartilage; 2021 Dec; 13(2_suppl):1345S-1355S. PubMed ID: 32037864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of lncRNA OIP5-AS1 Attenuates Apoptosis and Inflammation, and Promotes Proliferation by Mediating miR-25-3p Expression in Lipopolysaccharide-Induced Myocardial Injury.
    Ma J; Qian H; Zou H
    Anal Cell Pathol (Amst); 2023; 2023():3154223. PubMed ID: 36994450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA OIP5-AS1/miR-410-3p/Wnt7b axis promotes the proliferation of rheumatoid arthritis fibroblast-like synoviocytes via regulating the Wnt/β-catenin pathway.
    Sun Y; Jiang H; Pan L; Han Y; Chen Y; Jiang Y; Wang Y
    Autoimmunity; 2023 Dec; 56(1):2189136. PubMed ID: 36942896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes.
    Zhang X; Wang Z; Wang B; Li J; Yuan H
    Open Med (Wars); 2023; 18(1):20230721. PubMed ID: 37333451
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Song Z; Han Q; Wen Z; Lv Q; Pan C; Pan Y
    Ann Transl Med; 2023 Feb; 11(3):143. PubMed ID: 36846012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OIP5-AS1 accelerates apoptosis of hippocampal neurons in cell models of epilepsy by modulating MiR-128-3p/BAX axis.
    Ye Z; Guan X; Shan W; Ma B
    Prev Med; 2023 Aug; 173():107565. PubMed ID: 37268172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
    Zhi XH; Jiang K; Ma YY; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA OIP5-AS1 knockdown or miR-223 overexpression can alleviate LPS-induced ALI/ARDS by interfering with miR-223/NLRP3-mediated pyroptosis.
    Ji J; Ye W; Sun G
    J Gene Med; 2022 Apr; 24(4):e3385. PubMed ID: 34346534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis.
    Liu L; Wang S
    Onco Targets Ther; 2020; 13():3853-3866. PubMed ID: 32440152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis.
    Xiao Z; Li J; Jin Q; Liu D
    Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis.
    Zhang C; Wang L; Shen Y
    BMC Cardiovasc Disord; 2021 Apr; 21(1):207. PubMed ID: 33892646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.